Bruxism in patients of moderate to severe traumatic brain injury: Management results suggesting an etiological mechanism

Bruxism is distressing to a patient-in-recovery following brain injury and cause significant inconvenience to the nursing staff. Effective treatment included the use of benzodiazepines and pramipexole. Pramipexole, a dopamine receptor agonist, should be considered an option for pharmacological management of bruxism after brain trauma. If central pattern generators (CPG) are involved in some of the disabilities of moderate to severe brain injuries like bruxism, there is a rationale for considering a larger study for the use of dopamine receptor agonist in such patients.